227 related articles for article (PubMed ID: 24854630)
1. Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.
Chen Z; Gulzar ZG; St Hill CA; Walcheck B; Brooks JD
Prostate; 2014 Jul; 74(10):1059-67. PubMed ID: 24854630
[TBL] [Abstract][Full Text] [Related]
2. [Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer].
Ohyama C; Yoneyama T; Tobisawa Y; Ishikawa T; Hatakeyama S; Koie T; Mori K
Rinsho Byori; 2017 Feb; 65(2):210-217. PubMed ID: 30762989
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma.
Borzym-Kluczyk M; Radziejewska I; Cechowska-Pasko M
Clin Exp Nephrol; 2015 Aug; 19(4):732-7. PubMed ID: 25091456
[TBL] [Abstract][Full Text] [Related]
4. O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.
Premaratne P; Welén K; Damber JE; Hansson GC; Bäckström M
Tumour Biol; 2011 Feb; 32(1):203-13. PubMed ID: 20872286
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
[TBL] [Abstract][Full Text] [Related]
6. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes.
Beum PV; Singh J; Burdick M; Hollingsworth MA; Cheng PW
J Biol Chem; 1999 Aug; 274(35):24641-8. PubMed ID: 10455130
[TBL] [Abstract][Full Text] [Related]
7. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
[TBL] [Abstract][Full Text] [Related]
8. Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.
Sato T; Yoneyama T; Tobisawa Y; Hatakeyama S; Yamamoto H; Kojima Y; Mikami J; Mori K; Hashimoto Y; Koie T; Ohyama C
Biochem Biophys Res Commun; 2016 Jan; 470(1):150-156. PubMed ID: 26768364
[TBL] [Abstract][Full Text] [Related]
9. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
[TBL] [Abstract][Full Text] [Related]
10. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
Grob BM; Schellhammer PF; Brassil DN; Wright GL
Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.
Fernandez-Rodriguez J; Dwir O; Alon R; Hansson GC
Glycoconj J; 2001; 18(11-12):925-30. PubMed ID: 12820726
[TBL] [Abstract][Full Text] [Related]
12. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
[TBL] [Abstract][Full Text] [Related]
13. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
14. The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer.
Hodgson K; Orozco-Moreno M; Scott E; Garnham R; Livermore K; Thomas H; Zhou Y; He J; Bermudez A; Garcia Marques FJ; Bastian K; Hysenaj G; Archer Goode E; Heer R; Pitteri S; Wang N; Elliott DJ; Munkley J
Sci Rep; 2023 Oct; 13(1):17031. PubMed ID: 37813880
[TBL] [Abstract][Full Text] [Related]
15. Prostatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis a.
Chachadi VB; Ali MF; Cheng PW
PLoS One; 2013; 8(2):e57416. PubMed ID: 23451223
[TBL] [Abstract][Full Text] [Related]
16. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.
Papadopoulos I; Sivridis E; Giatromanolaki A; Koukourakis MI
Clin Cancer Res; 2001 Jun; 7(6):1533-8. PubMed ID: 11410487
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
Hakalahti L; Vihko P; Henttu P; Autio-Harmainen H; Soini Y; Vihko R
Int J Cancer; 1993 Oct; 55(4):590-7. PubMed ID: 7691762
[TBL] [Abstract][Full Text] [Related]
18. Changes in tissue prostatic acidic phosphatase during endocrine treatment of patients with prostatic carcinoma.
Grande M; Carlström K; Lundh-Rozell B; Stege R; Pousette A
Scand J Urol Nephrol; 2005; 39(5):393-8. PubMed ID: 16257841
[TBL] [Abstract][Full Text] [Related]
19. Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
Kojima Y; Yoneyama T; Hatakeyama S; Mikami J; Sato T; Mori K; Hashimoto Y; Koie T; Ohyama C; Fukuda M; Tobisawa Y
PLoS One; 2015; 10(9):e0138520. PubMed ID: 26390303
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability.
Munkley J; Vodak D; Livermore KE; James K; Wilson BT; Knight B; Mccullagh P; Mcgrath J; Crundwell M; Harries LW; Leung HY; Robson CN; Mills IG; Rajan P; Elliott DJ
EBioMedicine; 2016 Jun; 8():103-116. PubMed ID: 27428423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
